Get the Stockscreener App
86.54
0.46%
-0.40
After Hours:
86.60
0.06
+0.07%
Vaneck Pharmaceutical Etf stock is traded at $86.54, with a volume of 193.43K.
It is down -0.46% in the last 24 hours and down -1.03% over the past month.
See More
Previous Close:
$86.94
Open:
$86.03
24h Volume:
193.43K
Relative Volume:
1.05
Market Cap:
$907.13M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.46%
1M Performance:
-1.03%
6M Performance:
-5.85%
1Y Performance:
+8.84%
1-Day Range:
$85.97
$87.24
1-Week Range:
$85.97
$88.95
52-Week Range:
$79.95
$99.51
Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
Name
Vaneck Pharmaceutical Etf
Sector
Industry
Phone
-
Address
-
Compare PPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PPH
Vaneck Pharmaceutical Etf
|
86.54 | 907.13M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
293.28 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
591.15 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
593.33 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
242.75 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
518.66 | 124.43B | 0 | 0 | 0 | 0.00 |
Vaneck Pharmaceutical Etf Stock (PPH) Latest News
PPH Is a Pertinent Healthcare Idea for 2025 - ETF Trends
Broad Market Gains Shape Moat Strategies for 2025 - VanEck
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - MSN
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - MSN
Bank of Montreal Can Grows Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
The Inflation Reduction Act: A Green Catalyst - VanEck
Winners And Losers: Post-Election Options Analysis - Barchart
Big Pharma earnings season in spotlight amid positive sentiment - MSN
Are Wall Street Analysts Predicting Cencora Stock Will Climb or Sink? - MSN
VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Strong Trading Volume – Time to Buy? - Defense World
US Bancorp DE Cuts Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
The U.S. Shakes Up Global Pharma Supply Chains - Seeking Alpha
Trading The Shit Show: November 2024 Market Review - substack.com
AbbVie shares slip after schizophrenia drug trial misses primary endpoint - MSN
Health Care Roundup: Market Talk - MSN
RAPT scraps zelnecirnon program, stock plunges 44% - MSN
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - MSN
JPMorgan BetaBuilders U.S. Treasury Bond 20+ Year ETF declares monthly distribution of $0.3949 - MSN
Invesco BulletShares 2028 Municipal Bond ETF declares monthly distribution of $0.0567 - MSN
5 Biggest Pharmaceutical ETFs in 2024 - Investing News Network
Stocks And ETFs In Focus As Americans Head To Polls - Barchart
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - MSN
From Gold to Digital Gold: VanEck's Journey with Crypto - VanEck
Vontobel Holding Ltd. Cuts Stock Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
BUZZ Investing: Fed’s 50 bps Rate Cut Market Rally - VanEck
Default Risk Eases For Most U.S. Market Sectors In Q3 2024 - Seeking Alpha
ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike - Yahoo Finance
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR - Yahoo Finance
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win - Yahoo Finance
The Growing Role of AI in Nuclear Energy Investing - VanEck
Diversified Exposure To The Weight Loss Drug Market - Seeking Alpha
Teva Pharmaceutical hits a new 52-week high - MSN
Pharma stocks analysis: Pfizer, Bristol-Myers Squibb, AbbVie - MSN
Thermo Fisher plant making Astra/ Sanofi RSV drug reportedly breached FDA rules - MSN
Pharma Stocks Losing Ground After A Remarkable Rally, Downgrading PPH (NASDAQ:PPH) - Seeking Alpha
DBK Financial Counsel LLC Buys 142 Shares of Vanguard Intermediate-Term Bond ETF (NYSEARCA:BIV) - Defense World
Northwestern Mutual Wealth Management Co. Raises Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
General Electric (NYSE:GE) Shares Sold by B. Riley Wealth Advisors Inc. - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Stock Holdings Increased by Renaissance Technologies LLC - Defense World
Healthcare ETFs Starting to Look Healthy - ETFdb.com
ProShares UltraShort Russell2000 (NYSEARCA:TWM) Shares Cross Below 50 Day Moving Average of $9.88 - Defense World
JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI) Shares Acquired by Element Pointe Advisors LLC - Defense World
CLOBVanEck AA-BB CLO ETF | Holdings & Performance - VanEck
Three Forces Powering the Nuclear Energy Surge - VanEck
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Acquired by Beck Capital Management LLC - Defense World
DoubleLine’s Jeffrey Gundlach on the Fed, Gold and Private Credit - ETF Trends
Virtu Financial LLC Acquires New Position in Global X Uranium ETF (NYSEARCA:URA) - Defense World
Axxcess Wealth Management LLC Reduces Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Telecom Argentina (NYSE:TEO) Downgraded by Scotiabank - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Large Volume Increase - Defense World
VanEck Mid-September 2024 Bitcoin ChainCheck: 1-Year Review Edition - VanEck
Vaneck Pharmaceutical Etf Stock (PPH) Financials Data
There is no financial data for Vaneck Pharmaceutical Etf (PPH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.17%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):